juglone and plx4032
juglone has been researched along with plx4032 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chai, J; He, S; Li, M; Li, Z; Liu, X; Wu, J; Xu, J | 1 |
Other Studies
1 other study(ies) available for juglone and plx4032
| Article | Year |
|---|---|
Juglone potentiates BRAF inhibitor‑induced apoptosis in melanoma through reactive oxygen species and the p38‑p53 pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; MAP Kinase Signaling System; Melanoma; Naphthoquinones; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53; Vemurafenib | 2020 |